Abstract
Type I and III interferons (IFNs) both serve as pivotal components of the host antiviral innate immune system. Although they exert similar antiviral effects, type I IFNs can also activate neutrophil inflammation, a function not born by type III IFNs. Baicalin, the main bioactive component of Scutellariae radix, has been shown to exert therapeutic effects on viral diseases due to its anti-viral, anti-inflammatory and immunomulatory activities. There is uncertainty, however, on the association between the antiviral effects of baicalin and the modulation of anti-viral IFNs production and the immunological effects of type I IFNs. Here, a Poly (I:C)-stimulated A549 cell line was established to mimic a viral infection model. Our results demonstrated that baicalin could elevate the expression of type I and III IFNs and their receptors in Poly (I:C)-stimulated A549 cells. Moreover, the potential regulation effects of baicalin for type I IFN-induced neutrophil inflammation was further explored. Results showed that baicalin diminished the production of the pro-inflammatory cytokines (IL-1β, IL-6, IL-17 and TNF-α), ROS, and neutrophil extracellular traps and suppressed chemotaxis. Collectively, all these data indicated that baicalin had a dual role on IFNs production and effects: (1) Baicalin was able to elevate the expression of type I and III IFNs and their receptors, (2) and it alleviated type I IFN-mediated neutrophil inflammatory response. This meant that baicalin has the potential to act as an eximious immunomodulator, exerting antiviral effects and reducing inflammation.
Similar content being viewed by others
Availability of data and materials
All data included in this article are available from the corresponding author upon request.
References
Stanifer ML, Pervolaraki K, Boulant S (2019) Differential regulation of type I and type III interferon signaling. Int J Mol Sci 20:1445. https://doi.org/10.3390/ijms20061445
Dalskov L, Møhlenberg M, Thyrsted J, Blay-Cadanet J, Poulsen ET, Folkersen BH, Skaarup SH, Olagnier D, Reinert L, Enghild JJ, Hoffmann HJ, Holm CK, Hartmann R (2020) SARS-CoV-2 evades immune detection in alveolar macrophages. EMBO Rep 21:e51252. https://doi.org/10.15252/embr.202051252
Qiu L, Wang T, Tang Q, Li G, Wu P, Chen K (2018) Long non-coding RNAs: regulators of viral infection and the interferon antiviral response. Front Microbiol 9:1621. https://doi.org/10.3389/fmicb.2018.01621
McElrath C, Espinosa V, Lin J-D, Peng J, Sridhar R, Dutta O, Tseng H-C, Smirnov SV, Risman H, Sandoval MJ, Davra V, Chang Y-J, Pollack BP, Birge RB, Galan M, Rivera A, Durbin JE, Kotenko SV (2021) Critical role of interferons in gastrointestinal injury repair. Nat Commun 12:2624. https://doi.org/10.1038/s41467-021-22928-0
Stegelmeier AA, Darzianiazizi M, Hanada K, Sharif S, Wootton SK, Bridle BW, Karimi K (2021) Type I interferon-mediated regulation of antiviral capabilities of neutrophils. Int J Mol Sci 22:4726. https://doi.org/10.3390/ijms22094726
Monack DM, Murdoch CC, Espenschied ST, Matty MA, Mueller O, Tobin DM, Rawls JF (2019) Intestinal serum amyloid A suppresses systemic neutrophil activation and bactericidal activity in response to microbiota colonization. PLOS Pathog 15:e1007381. https://doi.org/10.1371/journal.ppat.1007381
Galani IE, Triantafyllia V, Eleminiadou E-E, Koltsida O, Stavropoulos A, Manioudaki M, Thanos D, Doyle SE, Kotenko SV, Thanopoulou K, Andreakos E (2017) Interferon-λ mediates non-redundant front-line antiviral protection against influenza virus infection without compromising host fitness. Immunity 46:875-890.e876. https://doi.org/10.1016/j.immuni.2017.04.025
Moreira-Teixeira L, Stimpson PJ, Stavropoulos E, Hadebe S, Chakravarty P, Ioannou M, Aramburu IV, Herbert E, Priestnall SL, Suarez-Bonnet A, Sousa J, Fonseca KL, Wang Q, Vashakidze S, Rodríguez-Martínez P, Vilaplana C, Saraiva M, Papayannopoulos V, O’Garra A (2020) Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nat Commun 11:5566. https://doi.org/10.1038/s41467-020-19412-6
Glennon-Alty L, Moots RJ, Edwards SW, Wright HL (2021) Type I interferon regulates cytokine-delayed neutrophil apoptosis, reactive oxygen species production and chemokine expression. Clin Exp Immunol 203:151–159. https://doi.org/10.1111/cei.13525
Evans HM, Schultz DF, Boiman AJ, McKell MC, Qualls JE, Deepe GS, Wormley FL (2021) Restraint of fumarate accrual by HIF-1α preserves miR-27a-mediated limitation of interleukin 10 during infection of macrophages by histoplasma capsulatum. MBio 12:e0271021. https://doi.org/10.1128/mBio.02710-21
Peng Y, Wu X, Zhang S, Deng C, Zhao L, Wang M, Wu Q, Yang H, Zhou J, Peng L, Luo X, Chen Y, Wang A, Xiao Q, Zhang W, Zhao Y, Zeng X, Fei Y (2022) The potential roles of type I interferon activated neutrophils and neutrophil extracellular traps (NETs) in the pathogenesis of primary Sjögren’s syndrome. Arthritis Res Ther 24:170. https://doi.org/10.1186/s13075-022-02860-4
Ding Y, Ouyang Z, Zhang C, Zhu Y, Xu Q, Sun H, Qu J, Sun Y (2022) Tyrosine phosphatase SHP2 exacerbates psoriasis-like skin inflammation in mice via ERK5-dependent NETosis. MedComm. https://doi.org/10.1002/mco2.120
Pylaeva E, Bordbari S, Spyra I, Decker AS, Häussler S, Vybornov V, Lang S, Jablonska J (2019) Detrimental effect of type I IFNs during acute lung infection with pseudomonas aeruginosa is mediated through the stimulation of neutrophil NETosis. Front Immunol 10:2190. https://doi.org/10.3389/fimmu.2019.02190
Zhu Y, Ouyang Z, Du H, Wang M, Wang J, Sun H, Kong L, Xu Q, Ma H, Sun Y (2022) New opportunities and challenges of natural products research: When target identification meets single-cell multiomics. Acta Pharmaceutica Sinica B 12:4011–4039. https://doi.org/10.1016/j.apsb.2022.08.022
Stegelmeier AA, Chan L, Mehrani Y, Petrik JJ, Wootton SK, Bridle B, Karimi K (2020) Characterization of the impact of oncolytic vesicular stomatitis virus on the trafficking, phenotype, and antigen presentation potential of neutrophils and their ability to acquire a non-structural viral protein. Int J Mol Sci 21:6347. https://doi.org/10.3390/ijms21176347
Hsu M-J, Lee S-S, Lee ST, Lin W-W (2003) Signaling mechanisms of enhanced neutrophil phagocytosis and chemotaxis by the polysaccharide purified from Ganoderma lucidum. Br J Pharmacol 139:289–298. https://doi.org/10.1038/sj.bjp.0705243
Yang W-L, Sharma A, Zhang F, Matsuo S, Wang Z, Wang H, Wang P (2015) Milk fat globule epidermal growth factor-factor 8-derived peptide attenuates organ injury and improves survival in sepsis. Crit Care 19:375. https://doi.org/10.1186/s13054-015-1094-3
Koupenova M, Corkrey HA, Vitseva O, Manni G, Pang CJ, Clancy L, Yao C, Rade J, Levy D, Wang JP, Finberg RW, Kurt-Jones EA, Freedman JE (2019) The role of platelets in mediating a response to human influenza infection. Nat Commun 10:1780. https://doi.org/10.1038/s41467-019-09607-x
Wu Y, Jin YZ, Wu J, Yu X, Hao Y (2010) Antiviral effect of major constituents of Huangqin (Radix Scutellariae) on influenza A virus (FM1) in vitro. J Beijing Univ Tradit Chin Med 33:541–545
Li K, Li YAN, Ma Z, Zhao JIE (2015) Crocin exerts anti-inflammatory and anti-catabolic effects on rat intervertebral discs by suppressing the activation of JNK. Int J Mol Med 36:1291–1299. https://doi.org/10.3892/ijmm.2015.2359
Zhang Q, Sun J, Fu Y, He W, Li Y, Tan H, Xu H, Jiang X (2020) Guttiferone K exerts the anti-inflammatory effect on mycobacterium tuberculosis- (H37Ra-) infected macrophages by targeting the TLR/IRAK-1 mediated Akt and NF-κB pathway. Mediators Inflamm 2020:1–16. https://doi.org/10.1155/2020/8528901
Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in Inflammation and tissue injury. Antioxid Redox Signal 20:1126–1167. https://doi.org/10.1089/ars.2012.5149
Martinelli S, Urosevic M, Daryadel A, Oberholzer PA, Baumann C, Fey MF, Dummer R, Simon H-U, Yousefi S (2004) Induction of genes mediating interferon-dependent extracellular trap formation during neutrophil differentiation. J Biol Chem 279:44123–44132. https://doi.org/10.1074/jbc.M405883200
Acknowledgements
The authors thank all those who contributed to this work.
Funding
This study received funding from National Natural Science Foundation of China [No. 82160835], Guangxi Natural Science Foundation [No. 2021GXNSFAA196053], Science and Technology Program of Liuzhou [No. 2022SB001, and 2021CBB0101], Guangxi Basic Ability Promotion Project of Middle-aged and Young Teachers in Colleges and Universities [No. 2022KY0096], and Scientific Research Project of Liuzhou People’s Hospital affiliated to Guangxi Medical University [No. lry202203, and No. lry202210].
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All authors declare that there is no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Li, L., Dong, JM., Ye, HH. et al. Baicalin promotes antiviral IFNs production and alleviates type I IFN-induced neutrophil inflammation. J Nat Med 77, 677–687 (2023). https://doi.org/10.1007/s11418-023-01702-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11418-023-01702-0